Efficacy News and Research

RSS
ViroPharma presents Cinryze data against HAE at AAAAI Annual Meeting

ViroPharma presents Cinryze data against HAE at AAAAI Annual Meeting

FDA approves Harvest's BMAC System IDE trial to treat non-reconstructable Critical Limb Ischemia

FDA approves Harvest's BMAC System IDE trial to treat non-reconstructable Critical Limb Ischemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

Enrollment complete in Aradigm's inhaled ciprofloxacin Phase 2b study in non-cystic fibrosis bronchiectasis

Astellas announces positive results from mirabegron phase III trials against OAB

Astellas announces positive results from mirabegron phase III trials against OAB

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

Nordic Naturals introduces Kenai Wild Alaskan Salmon Oil

Nordic Naturals introduces Kenai Wild Alaskan Salmon Oil

Researchers launch free online Atlas of TB vaccination policies around the world

Researchers launch free online Atlas of TB vaccination policies around the world

Positive results from Meda's Dymista Phase III trial in patients with SAR

Positive results from Meda's Dymista Phase III trial in patients with SAR

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

Shire's Replagal and VPRIV data on Gaucher and Fabry patients presented at ACMG meeting

CSL Behring presents Hizentra study data against PI at AAAAI meeting

CSL Behring presents Hizentra study data against PI at AAAAI meeting

Ventirx VTX-1463 positive clinical data against allergic rhinitis presented at AAAAI meeting

Ventirx VTX-1463 positive clinical data against allergic rhinitis presented at AAAAI meeting

FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial

FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial

Rxi's new RNAi preclinical data to be presented at Keystone conference

Rxi's new RNAi preclinical data to be presented at Keystone conference

Cephalon to acquire Gemin X Pharmaceuticals

Cephalon to acquire Gemin X Pharmaceuticals

Differences between therapeutic radiation therapy and exposure to excessive nuclear plant fallout radiation

Differences between therapeutic radiation therapy and exposure to excessive nuclear plant fallout radiation

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

NasVax reports positive results from Phase 2a trial of oral immunotherapy for non-alcoholic steatohepatitis

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

FDA clears Insmed IND for ARIKACE Phase 3 clinical trial in nontuberculous mycobacteria lung infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.